These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18560230)

  • 21. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl.
    Racette AJ; Roenigk HH; Hansen R; Mendelson D; Park A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S81-5. PubMed ID: 15858516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of the solvent vehicle sulphobutylether beta cyclodextrin sodium in critically ill patients treated with intravenous voriconazole under renal replacement therapy.
    von Mach MA; Burhenne J; Weilemann LS
    BMC Clin Pharmacol; 2006 Sep; 6():6. PubMed ID: 16981986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy.
    McCarthy KL; Playford EG; Looke DF; Whitby M
    Clin Infect Dis; 2007 Mar; 44(5):e55-6. PubMed ID: 17278050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients.
    Berge M; Guillemain R; Boussaud V; Pham MH; Chevalier P; Batisse A; Amrein C; Dannaoui E; Loriot MA; Lillo-Le Louet A; Billaud EM
    Transpl Infect Dis; 2009 Jun; 11(3):211-9. PubMed ID: 19302272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary prophylaxis with voriconazole in a leukemic patient with pulmonary aspergillosis.
    Uriz J; de Andoin NG; Calvo C; Landa J; Onate E; Nogues A; Guerrero R
    Pediatr Infect Dis J; 2007 Oct; 26(10):971-2. PubMed ID: 17901816
    [No Abstract]   [Full Text] [Related]  

  • 27. Voriconazole-induced pancreatitis in a patient of acute myeloid leukemia and invasive aspergillosis.
    Philip A; Sivaprakasam P; Sagar TG; Ganesan P
    J Pediatr Hematol Oncol; 2012 Jul; 34(5):406. PubMed ID: 22713708
    [No Abstract]   [Full Text] [Related]  

  • 28. Successful salvage treatment of Scedosporium apiospermum keratitis with topical voriconazole after failure of natamycin.
    Al-Badriyeh D; Leung L; Davies GE; Stewart K; Kong D
    Ann Pharmacother; 2009 Jun; 43(6):1139-42. PubMed ID: 19435962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug interaction between voriconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplant recipients.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2009 Sep; 44(6):371-4. PubMed ID: 19270729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients.
    Conlon JD; Dauenhauer M; Tonkovic-Capin V; Talano J; Margolis D; Drolet BA; Fairley JA
    J Am Acad Dermatol; 2008 Mar; 58(3):484-7. PubMed ID: 18280346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic drug monitoring of voriconazole in a child with invasive aspergillosis requiring extracorporeal membrane oxygenation.
    Brüggemann RJ; Antonius T; Heijst Av; Hoogerbrugge PM; Burger DM; Warris A
    Ther Drug Monit; 2008 Dec; 30(6):643-6. PubMed ID: 19057370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment with voriconazole for invasive fungal infection during chemotherapy for leukemia: doses and plasma concentration of voriconazole in children].
    Fukushima K; Fujisawa M; Nakajima D; Matsunaga T; Hagisawa S; Kurosawa H; Sugita K; Arisaka O
    Rinsho Ketsueki; 2007 May; 48(5):402-6. PubMed ID: 17571586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Glackin L; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is the "therapeutic range" for voriconazole?
    Lewis RE
    Clin Infect Dis; 2008 Jan; 46(2):212-4. PubMed ID: 18171252
    [No Abstract]   [Full Text] [Related]  

  • 35. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices?
    Pongas GN; Lewis RE; Samonis G; Kontoyiannis DP
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():93-7. PubMed ID: 19754766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic drug monitoring of voriconazole.
    Brüggemann RJ; Donnelly JP; Aarnoutse RE; Warris A; Blijlevens NM; Mouton JW; Verweij PE; Burger DM
    Ther Drug Monit; 2008 Aug; 30(4):403-11. PubMed ID: 18641555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment with voriconazole of Aspergillus meningitis in a patient with acute myeloid leukemia.
    Saitoh T; Matsushima T; Shimizu H; Yokohama A; Irisawa H; Handa H; Tsukamoto N; Karasawa M; Nojima Y; Murakami H
    Ann Hematol; 2007 Sep; 86(9):697-8. PubMed ID: 17431625
    [No Abstract]   [Full Text] [Related]  

  • 38. Voriconazole plasma monitoring.
    Pasqualotto AC; Shah M; Wynn R; Denning DW
    Arch Dis Child; 2008 Jul; 93(7):578-81. PubMed ID: 18252755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy.
    Brunel AS; Fraisse T; Lechiche C; Pinzani V; Mauboussin JM; Sotto A
    AIDS; 2008 Apr; 22(7):905-6. PubMed ID: 18427212
    [No Abstract]   [Full Text] [Related]  

  • 40. Dose tolerability of chronically inhaled voriconazole solution in rodents.
    Tolman JA; Nelson NA; Bosselmann S; Peters JI; Coalson JJ; Wiederhold NP; Williams RO
    Int J Pharm; 2009 Sep; 379(1):25-31. PubMed ID: 19524030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.